
Cardiac Monitoring Market - Global Outlook & Forecast 2022-2027
Description
Cardiac Monitoring Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Cardiac Monitoring Market Report
COVID-19 led to an increasing preference for remote monitoring patients with cardiovascular conditions. The government and some vendors have also taken various steps to raise awareness among patients and the public. September marks National Atrial Fibrillation (AF) Awareness Month, a critically important time for the Heart Rhythm Society to raise awareness for this life-threatening arrhythmia. The market is expected to grow significantly during the forecast period due to increasing technological advancements, new product launches, increasing elderly population, and reimbursement policies for implantable cardiac monitors & other ambulatory devices. Moreover, the COVID-19 impact will result in AI-based cardiac monitoring devices gaining traction across all regions.
The cardiac monitoring market is expected to grow at a CAGR of 5.86% during the forecast period
MARKET OPPORTUNITIES AND GROWTH DRIVERS
Based on mode, the global cardiac monitoring market is segmented into standard and ambulatory. The ambulatory cardiac monitoring market will grow with an absolute rate of 79.5% in the forecast period. Based on end-user, the global Cardiac Monitoring market is segmented into hospitals, specialty cardiac centers and clinics, diagnostic centers and others.The hospital segment had the highest share amongst end-users.
BY GEOGRAPHY
VENDOR LANDSCAPE
Major vendors in the cardiac monitoring market include Abbott, Boston Scientific, Medtronic, GE Healthcare, Philips Healthcare, Mortara Instrument and Welch Allyn owned by Hill-Rom Services, Spacelabs Healthcare owned by OSI Systems, and iRhythm Technologies.
THE REPORT INCLUDES:
1. The analysis of the global cardiac monitoring market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the cardiac monitoring market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global cardiac monitoring market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Cardiac Monitoring Market Report
COVID-19 led to an increasing preference for remote monitoring patients with cardiovascular conditions. The government and some vendors have also taken various steps to raise awareness among patients and the public. September marks National Atrial Fibrillation (AF) Awareness Month, a critically important time for the Heart Rhythm Society to raise awareness for this life-threatening arrhythmia. The market is expected to grow significantly during the forecast period due to increasing technological advancements, new product launches, increasing elderly population, and reimbursement policies for implantable cardiac monitors & other ambulatory devices. Moreover, the COVID-19 impact will result in AI-based cardiac monitoring devices gaining traction across all regions.
The cardiac monitoring market is expected to grow at a CAGR of 5.86% during the forecast period
MARKET OPPORTUNITIES AND GROWTH DRIVERS
- Technological Advancements in Cardiac Monitoring
- Increase in Demand for Compact, Mobile, & Wearable Cardiac Monitors
- Artificial Intelligence in Cardiac Monitoring
- The increasing global prevalence of cardiovascular diseases
- Growing Popularity of Smart Wearable Cardiac Monitoring Devices
Based on mode, the global cardiac monitoring market is segmented into standard and ambulatory. The ambulatory cardiac monitoring market will grow with an absolute rate of 79.5% in the forecast period. Based on end-user, the global Cardiac Monitoring market is segmented into hospitals, specialty cardiac centers and clinics, diagnostic centers and others.The hospital segment had the highest share amongst end-users.
BY GEOGRAPHY
- North America, Europe, APAC, Latin America, Middle East & Africa
VENDOR LANDSCAPE
Major vendors in the cardiac monitoring market include Abbott, Boston Scientific, Medtronic, GE Healthcare, Philips Healthcare, Mortara Instrument and Welch Allyn owned by Hill-Rom Services, Spacelabs Healthcare owned by OSI Systems, and iRhythm Technologies.
THE REPORT INCLUDES:
1. The analysis of the global cardiac monitoring market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the cardiac monitoring market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global cardiac monitoring market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
361 Pages
- 1 Research Methodology
- 2 Research Objectives
- 3 Research Process
- 4 Scope & Coverage
- 4.1 Market Definition
- 4.1.1 Inclusions
- 4.1.2 Exclusions
- 4.2 Base Year
- 4.3 Scope of The Study
- 4.4 Market Segmentation
- 4.4.1 Market Segmentation by Product
- 4.4.2 Market Segmentation by Mode
- 4.4.3 Market Segmentation by End-User
- 4.4.4 Market Segmentation by Geography
- 5 Report Assumptions & Caveats
- 5.1 Key Caveats
- 5.2 Currency Conversion
- 5.3 Market Derivation
- 6 Market at a Glance
- 7 Introduction
- 7.1 Overview
- 7.1.1 Cardiac Monitoring Devices
- 7.1.2 Ambulatory Cardiac Monitoring
- 7.1.3 Privacy & Data Security for Wearable Cardiac Monitoring Platforms
- 7.1.4 Digital Health Adoption Increasing in Cardiac Monitoring
- 8 Market Opportunities & Trends
- 8.1 Technological Advances in Cardiac Monitoring Devices
- 8.2 Increase in Demand for Compact, Mobile, & Wearable Cardiac Monitors
- 8.3 Artificial Intelligence in Cardiac Monitoring
- 9 Market Growth Enablers
- 9.1 Increasing Global Prevalence of Cardiovascular Diseases
- 9.2 Growing Popularity of Smart Wearable Cardiac Monitoring Devices
- 9.3 New Product Launches in Cardiac Monitoring Market
- 9.4 Growing Focus on Mergers & Acquisitions
- 10 Market Growth Restraints
- 10.1 Limitations & Risks Associated with Cardiac Monitoring Devices
- 10.2 Stringent Regulatory Scenario
- 10.3 Dearth of Skilled Professionals
- 10.4 High Cost of Equipment & Infrastructure
- 11 Market Landscape
- 11.1 Market Overview
- 11.2 Market Size & Forecast
- 11.2.1 Geography Insights
- 11.2.2 Product Insights
- 11.2.3 Usage Mode Insights
- 11.2.4 End-User Insights
- 11.3 Five Forces Analysis
- 11.3.1 Threat of New Entrants
- 11.3.2 Bargaining Power of Suppliers
- 11.3.3 Bargaining Power of Buyers
- 11.3.4 Threat of Substitutes
- 11.3.5 Competitive Rivalry
- 12 Product
- 12.1 Market Snapshot & Growth Engine
- 12.2 Market Overview
- 12.3 Resting ECG
- 12.3.1 Market Overview
- 12.3.2 Market Size & Forecast
- 12.3.3 Resting ECG: Geography Segmentation
- 12.4 Stress ECG
- 12.4.1 Market Overview
- 12.4.2 Market Size & Forecast
- 12.4.3 Stress ECG: Geography Segmentation
- 12.5 Cardiac Event Monitoring
- 12.5.1 Market Overview
- 12.5.2 Market Size & Forecast
- 12.5.3 Cardiac Event Monitoring: Geography Segmentation
- 12.6 Mobile Cardiac Telemetry
- 12.6.1 Market Overview
- 12.6.2 Market Size & Forecast
- 12.6.3 Mobile Cardiac Telemetry: Geography Segmentation
- 12.7 Holter Monitoring
- 12.7.1 Market Overview
- 12.7.2 Market Size & Forecast
- 12.7.3 Holter Monitoring: Geography Segmentation
- 12.8 Cardiac Output Monitoring
- 12.8.1 Market Overview
- 12.8.2 Market Size & Forecast
- 12.8.3 Cardiac Output Monitoring: Geography Segmentation
- 12.9 Implantable Cardiac Monitoring
- 12.9.1 Market Overview
- 12.9.2 Market Size & Forecast
- 12.9.3 Implantable Cardiac Monitoring: Geography Segmentation
- 13 Mode
- 13.1 Market Snapshot & Growth Engine
- 13.2 Market Overview
- 13.3 Ambulatory
- 13.3.1 Market Overview
- 13.3.2 Market Size & Forecast
- 13.3.3 Ambulatory: Geography Segmentation
- 13.4 Standard
- 13.4.1 Market Overview
- 13.4.2 Market Size & Forecast
- 13.4.3 Standard: Geography Segmentation
- 14 End-User
- 14.1 Market Snapshot & Growth Engine
- 14.2 Market Overview
- 14.3 Hospitals
- 14.3.1 Market Overview
- 14.3.2 Market Size & Forecast
- 14.3.3 Hospitals: Geography Segmentation
- 14.4 Specialty Cardiac Centers & Clinics
- 14.4.1 Market Overview
- 14.4.2 Market Size & Forecast
- 14.4.3 Specialty Cardiac Centers & Clinics: Geography Segmentation
- 14.5 Diagnostic Centers
- 14.5.1 Market Overview
- 14.5.2 Market Size & Forecast
- 14.5.3 Diagnostic Centers: Geography Segmentation
- 14.6 Others
- 14.6.1 Market Overview
- 14.6.2 Market Size & Forecast
- 14.6.3 Others: Geography Segmentation
- 15 Geography
- 15.1 Market Snapshot & Growth Engine
- 15.2 Geographic Overview
- 16 North America
- 16.1 Market Overview
- 16.2 Market Size & Forecast
- 16.3 North America: Product Segmentation
- 16.4 North America: Mode Segmentation
- 16.5 North America: End-User Segmentation
- 16.6 Key Countries
- 16.6.1 US: Market Size & Forecast
- 16.6.2 Canada Market Size and Forecast
- 17 Europe
- 17.1 Market Overview
- 17.2 Market Size & Forecast
- 17.3 Europe: Product Segmentation
- 17.4 Europe: Mode Segmentation
- 17.5 Europe: End-User Segmentation
- 17.6 Key Countries
- 17.6.1 Germany: Market Size & Forecast
- 17.6.2 France: Market Size & Forecast
- 17.6.3 UK: Market Size & Forecast
- 17.6.4 Italy: Market Size & Forecast
- 17.6.5 Spain: Market Size & Forecast
- 18 APAC
- 18.1 Market Overview
- 18.2 Market Size & Forecast
- 18.3 APAC: Product Segmentation
- 18.4 APAC: Mode Segmentation
- 18.5 APAC: End-User Segmentation
- 18.6 Key Countries
- 18.6.1 China: Market Size & Forecast
- 18.6.2 Japan: Market Size & Forecast
- 18.6.3 India: Market Size & Forecast
- 18.6.4 Australia: Market Size & Forecast
- 18.6.5 South Korea: Market Size & Forecast
- 19 Latin America
- 19.1 Market Overview
- 19.2 Market Size & Forecast
- 19.3 Latin America: Product Segmentation
- 19.4 Latin America: Mode Segmentation
- 19.5 Latin America: End-User Segmentation
- 19.6 Key Countries
- 19.6.1 Brazil: Market Size & Forecast
- 19.6.2 Mexico: Market Size & Forecast
- 19.6.3 Argentina: Market Size & Forecast
- 20 Middle East & Africa
- 20.1 Market Overview
- 20.2 Market Size & Forecast
- 20.3 Middle East & Africa: Product Segmentation
- 20.4 Middle East & Africa: Mode Segmentation
- 20.5 Middle East & Africa: End-User Segmentation
- 20.6 Key Countries
- 20.6.1 Turkey: Market Size & Forecast
- 20.6.2 Saudi Arabia: Market Size & Forecast
- 20.6.3 South Africa: Market Size & Forecast
- 21 Competitive Landscape
- 21.1 Competition Overview
- 21.2 Market Share Analysis
- 21.2.1 Abbott
- 21.2.2 Boston Scientific
- 21.2.3 Ge Healthcare
- 21.2.4 Hill-Rom Services
- 21.2.5 IRHYTHM Technologies
- 21.2.6 Medtronic
- 21.2.7 OSI Systems
- 21.2.8 KONINKLIJKE Philips
- 22 Key Company Profiles
- 22.1 ABBOTT
- 22.1.1 Business Overview
- 22.1.2 Product Offerings
- 22.1.3 Key Strategies
- 22.1.4 Key Strengths
- 22.1.5 Key Opportunities
- 22.2 BOSTON SCIENTIFIC CORPORATION
- 22.2.1 Market Overview
- 22.2.2 Product Offerings
- 22.2.3 Key Strategies
- 22.2.4 Key Strengths
- 22.2.5 Key Opportunities
- 22.3 GE HEALTHCARE
- 22.3.1 Business Overview
- 22.3.2 Product Offerings
- 22.3.3 Key Strategies
- 22.3.4 Key Strengths
- 22.3.5 Key Opportunities
- 22.4 HILL-ROM SERVICES
- 22.4.1 Business Overview
- 22.4.2 Product Offerings
- 22.4.3 Key Strategies
- 22.4.4 Key Strengths
- 22.4.5 Key Opportunities
- 22.5 IRHYTHM TECHNOLOGIES
- 22.5.1 Market Overview
- 22.5.2 Product Offerings
- 22.5.3 Key Strategies
- 22.5.4 Key Strengths
- 22.5.5 Key Opportunities
- 22.6 MEDTRONIC
- 22.6.1 Business Overview
- 22.6.2 Product Offerings
- 22.6.3 Key Strategies
- 22.6.4 Key Strengths
- 22.6.5 Key Opportunities
- 22.7 OSI SYSTEMS
- 22.7.1 Market Overview
- 22.7.2 Product Offerings
- 22.7.3 Key Strategies
- 22.7.4 Key Strengths
- 22.7.5 Key Opportunities
- 22.8 KONINKLIJKE PHILIPS
- 22.8.1 Business Overview
- 22.8.2 Product Offerings
- 22.8.3 Key Strategies
- 22.8.4 Key Strength
- 22.8.5 Key Opportunities
- 23 Other Prominent Vendors
- 23.1 BPL MEDICAL TECHNOLOGIES
- 23.1.1 Business Overview
- 23.1.2 Product Offerings
- 23.2 BIOTRONIK
- 23.2.1 Market Overview
- 23.2.2 Product Offerings
- 23.3 BARDY DIAGNOSTICS
- 23.3.1 Business Overview
- 23.3.2 Product Offerings
- 23.4 BITTIUM
- 23.4.1 Business Overview
- 23.4.2 Product Offerings
- 23.5 CORTRIUM
- 23.5.1 Business Overview
- 23.5.2 Product Offerings
- 23.6 DELTEX MEDICAL
- 23.6.1 Business Overview
- 23.6.2 Product Offerings
- 23.7 EDWARDS LIFESCIENCES
- 23.7.1 Business Overview
- 23.7.2 Product Offerings
- 23.8 FUKUDA DENSHI
- 23.8.1 Business Overview
- 23.8.2 Product Offerings
- 23.9 GETINGE
- 23.9.1 Business Overview
- 23.9.2 Product Offerings
- 23.10 MASIMO
- 23.10.1 Business Overview
- 23.10.2 Product Offerings
- 23.11 MEDICALGORITHMICS
- 23.11.1 Business Overview
- 23.11.2 Product Offerings
- 23.12 AEROTEL MEDICAL SYSTEMS
- 23.12.1 Business Overview
- 23.12.2 Product Offerings
- 23.13 ACS DIAGNOSTICS
- 23.13.1 Business Overview
- 23.13.2 Product Offerings
- 23.14 SCOTTCARE CARDIOVASCULAR SOLUTIONS
- 23.14.1 Business Overview
- 23.14.2 Product Offerings
- 23.15 VASO CORPORATION
- 23.15.1 Business Overview
- 23.15.2 Product Offerings
- 23.16 SCHILLER
- 23.16.1 Business Overview
- 23.16.2 Product Offerings
- 23.17 ALIVECOR
- 23.17.1 Business Overview
- 23.17.2 Product Offerings
- 23.18 CARDIOCOMM SOLUTIONS
- 23.18.1 Business Overview
- 23.18.2 Product Offerings
- 23.19 IMEDRIX
- 23.19.1 Business Overview
- 23.19.2 Product Offerings
- 23.20 CONNECTED CARE INDIA
- 23.20.1 Business Overview
- 23.20.2 Product Offerings
- 23.21 ADVANCED INSTRUMENTATIONS
- 23.21.1 Business Overview
- 23.21.2 Product Offerings
- 23.22 AMEDTEC MEDIZINTECHNIK AUE
- 23.22.1 Business Overview
- 23.22.2 Product Offerings
- 23.23 ASPEL
- 23.23.1 Business Overview
- 23.23.2 Product Offerings
- 23.24 HANGZHOU BENEWARE MEDICAL EQUIPMENT
- 23.24.1 Business Overview
- 23.24.2 Product Offerings
- 23.25 BIOTRICITY
- 23.25.1 Business Overview
- 23.25.2 Product Offerings
- 23.26 BORSAM BIOMEDICAL INSTRUMENTS
- 23.26.1 Business Overview
- 23.26.2 Product Offerings
- 23.27 BTL
- 23.27.1 Business Overview
- 23.27.2 Product Offerings
- 23.28 CONTEC MEDICAL SYSTEMS
- 23.28.1 Business Overview
- 23.28.2 Product Offerings
- 23.29 CUSTO MED
- 23.29.1 Business Overview
- 23.29.2 Product Offerings
- 23.30 OY DIAGNOSTIC DEVICES DEVELOPMENT (DDD)
- 23.30.1 Business Overview
- 23.30.2 Product Offerings
- 23.31 DMS-SERVICE
- 23.31.1 Business Overview
- 23.31.2 Product Offerings
- 23.32 EB NEURO
- 23.32.1 Business Overview
- 23.32.2 Product Offerings
- 23.33 EDAN INSTRUMENTS
- 23.33.1 Business Overview
- 23.33.2 Product Offerings
- 23.34 FOREST MEDICAL
- 23.34.1 Business Overview
- 23.34.2 Product Offerings
- 23.35 HOLTER SUPPLIES
- 23.35.1 Business Overview
- 23.35.2 Product Offerings
- 23.36 LABTECH
- 23.36.1 Business Overview
- 23.36.2 Product Offerings
- 23.37 LEPU MEDICAL TECHNOLOGY (BEIJING)
- 23.37.1 Business Overview
- 23.37.2 Product Offerings
- 23.38 LUMED
- 23.38.1 Business Overview
- 23.38.2 Product Offerings
- 23.39 MEDICAL ECONET
- 23.39.1 Business Overview
- 23.39.2 Product Offerings
- 23.40 MEDICOMP
- 23.40.1 Business Overview
- 23.40.2 Product Offerings
- 23.41 MEDITECH KFT.
- 23.41.1 Business Overview
- 23.41.2 Product Offerings
- 23.42 MEDITECH EQUIPMENT
- 23.42.1 Business Overview
- 23.42.2 Product Offerings
- 23.43 MIDMARK
- 23.43.1 Business Overview
- 23.43.2 Product Offerings
- 23.44 MONITOR
- 23.44.1 Business Overview
- 23.44.2 Product Offerings
- 23.45 NASAN MEDICAL ELECTRONICS
- 23.45.1 Business Overview
- 23.45.2 Product Offerings
- 23.46 NASIFF ASSOCIATES
- 23.46.1 Business Overview
- 23.46.2 Product Offerings
- 23.47 NEUROSOFT
- 23.47.1 Business Overview
- 23.47.2 Product Offerings
- 23.48 NORAV MEDICAL
- 23.48.1 Business Overview
- 23.48.2 Product Offerings
- 23.49 NORTHEAST MONITORING
- 23.49.1 Business Overview
- 23.49.2 Product Offerings
- 23.50 RHYTHMEDIX
- 23.50.1 Business Overview
- 23.50.2 Product Offerings
- 23.51 REMO CARE SOLUTIONS
- 23.51.1 Business Overview
- 23.51.2 Product Offerings
- 24 Report Summary
- 24.1 Key Takeaways
- 24.2 Strategic Recommendations
- 25 Quantitative Summary
- 25.1 Market by Product
- 25.1.1 North America: Product Segmentation
- 25.1.2 Europe: Product Segmentation
- 25.1.3 APAC: Product Segmentation
- 25.1.4 Latin America: Product Segmentation
- 25.1.5 Middle East & Africa: Product Segmentation
- 25.2 Market by Mode
- 25.2.1 North America: Mode Segmentation
- 25.2.2 Europe: Mode Segmentation
- 25.2.3 APAC: Mode Segmentation
- 25.2.4 Latin America: Mode Segmentation
- 25.2.5 Middle East & Africa: Mode Segmentation
- 25.3 Market by End-User
- 25.3.1 North America: End-User Segmentation
- 25.3.2 Europe: End-User Segmentation
- 25.3.3 APAC: End-User Segmentation
- 25.3.4 Latin America: End-User Segmentation
- 25.3.5 Middle East & Africa: End-User Segmentation
- 25.4 Market by Geography
- 25.4.1 Resting ECG: Geography Segmentation
- 25.4.2 Stress ECG: Geography Segmentation
- 25.4.3 Mobile Cardiac Telemetry: Geography Segmentation
- 25.4.4 Holter Monitoring: Geography Segmentation
- 25.4.5 Implantable Cardiac Monitoring: Geography Segmentation
- 25.4.6 Cardiac Event Monitoring: Geography Segmentation
- 25.4.7 Cardiac Output Monitoring: Geography Segmentation
- 25.4.8 Standard: Geography Segmentation
- 25.4.9 Ambulatory: Geography Segmentation
- 25.4.10 Hospitals: Geography Segmentation
- 25.4.11 Specialty Cardiac Center & Clinics: Geography Segmentation
- 25.4.12 Diagnostic Centers: Geography Segmentation
- 25.4.13 Others: Geography Segmentation
- 26 Appendix
- 26.1 Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.